Bayesian Capital Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-41,425
| Closed | -$898K | – | 1079 |
|
|
2023
Q4 | $898K | Buy |
+41,425
| New | +$898K | 0.1% | 256 |
|
|
2022
Q4 | – | Sell |
-6,800
| Closed | -$266K | – | 1004 |
|
|
2022
Q3 | $266K | Buy |
+6,800
| New | +$266K | 0.05% | 450 |
|
|
2019
Q4 | – | Sell |
-1,827
| Closed | -$256K | – | 728 |
|
|
2019
Q3 | $256K | Buy |
+1,827
| New | +$256K | 0.05% | 398 |
|
|
2019
Q1 | – | Sell |
-2,290
| Closed | -$219K | – | 726 |
|
|
2018
Q4 | $219K | Buy |
+2,290
| New | +$219K | 0.04% | 496 |
|
|
2017
Q4 | – | Sell |
-4,492
| Closed | -$280K | – | 698 |
|
|
2017
Q3 | $280K | Buy |
+4,492
| New | +$280K | 0.07% | 379 |
|